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Abstract. In this paper a new simplified control scheme for the neuro-
muscular blockade level that only requires the knowledge of one model
parameter is proposed. The control law is designed to track a desired
target neuromuscular blockade level. Furthermore, an identification pro-
cedure to obtain the necessary model parameter is implemented. The
results were validated by simulations based on real data collected during
surgeries.
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1 Introduction
The impact of automatic control and system identification techniques on devices
and applications in the field of biomedicine has recently been growing. One ex-
ample of application of control to biomedical systems is the automatic control of
anesthetics during general surgery. In this case, several signals are taken into ac-
count to monitor the patient. One of these signals is the neuromuscular blockade
(NMB) level, which gives information about the patient’s state regarding muscle
paralysis, induced to allow the intubation and other clinical procedures. The de-
gree of the neuromuscular blockade can be assessed by applying a train-of-four of
supramaximal twitch stimulus to the hand peripheral nerve. The NMB level cor-
responds to the first response measured and varies between 100% (normal muscle
activity) and 0% (full paralysis). To achieve an adequate NMB level muscle re-
laxants are administered, e.g. rocuronium or atracurium. Mathematically, the
relation between the drug dose and its e↵ect can be modelled by a pharmacoki-
netic/pharmacodynamic (PK/PD) model. The pharmacokinetic model describes
the time course of the drug concentration in the plasma whereas the pharma-
codynamic model studies the relation between the drug concentration and its
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e↵ect. This latter relates the e↵ect concentration with the response by a non-
linear equation known as Hill equation, [1]. However, PK/PD models have the
drawback of needing a large number of parameters to characterize the patient. In
order to overcome this drawback a new simplified SISO Wiener model proposed
in [2] is used in this paper. This model involves a number minimal of patient-
dependent parameters. More concretely, it has one parameter in the linear part
of model and another one in the nonlinear part. Here, a new simplified control
law that only requires knowledge of the parameter associated to the nonlinear
model is proposed. This control law is based on the one proposed in [3], which
has already been applied to control the NMB level, using the two model parame-
ters [4], [5]. In order to implement our law, an estimation procedure for the only
parameter on which it depends is also proposed.
This paper is organized as follows. In Section 2 the SISO Wiener model and
the new control law are described. The main results are shown in Section 3, and
the conclusions are drawn in Section 4.
2 One-parameter Control law
This section presents our new positive control law for the NMB level that uses a
simplified description of the system. The underlying SISO Wiener NMB model
is first introduced.
2.1 SISO Wiener model
The NMB model proposed in [2] for the description of the e↵ect of the muscle
relaxant in the human body consists of one linear model followed by a nonlinear
static equation.
The linear dynamics is modeled by
Ce(s) =
k1 k2 k3 ↵3
(s+ k1↵)(s+ k2↵)(s+ k3↵)
U(s) , (1)
where Ce(s) is the Laplace transform of the e↵ect concentration ce(t); U(s) is
the Laplace transform of the input drug dose u(t); k1, k2 and k3 are parameters
that have been suitably determined in [2] for the muscle relaxants rocuronium
and atracurium, and ↵ > 0 is patient–dependent parameter.
The state–space representation of the model is(
x˙(t) = ↵Ax(t) + ↵Bu(t)
ce(t) =
⇥
0 0 1
⇤
x(t)
(2)
where the matrix A and the vector B are defined as
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A =
24 k3 0 0k2  k2 0
0 k1  k1
35 , B =
24 k30
0
35
The nonlinear static equation to describe the relation between the e↵ect
concentration and the actual drug e↵ect is given by the following Hill’s equation
y(t) =
100
1 +
⇣
ce(t)
C50
⌘  (3)
where C50 is the half of the maximum e↵ect concentration and has fixed value
according [6];   is the only other patient-dependent parameter.
2.2 Control law for the NMB level
The control law used in this paper is basically the one introduced in [3], which
applied to control the NMB level in [4] and [5]. The di↵erence is that, here,
the controller is independent from the parameter ↵, which constitutes a sim-
plification with respect to the previous approaches. Both the original and our
simplified law have the convergence of the total system mass M(x) =
P3
i=1 xi to
a desired system mass M⇤ as control objective. So, our aim of tracking a desired
NMB level is achieved by reaching and maintaining an appropriate mass of drug
in the patient’s body (or system). More concretely, the simplified control law
obtained is
8>><>>:
u(t) = max(0, u˜(t))
u˜(t) =  
 
3X
i=1
bi
! 1 ⇥⇥
1 1 1
⇤
)Ax(t) +  (M(x) M⇤)⇤ (4)
with   > 0 being a design parameter. Note the absence of the parameter ↵ from
(2). The parameter   from (3) is implicitely present as it is used to compute M⇤.
The proof that this control law achieves its mass tracking goal is similar to
the one given in [3]. Here, just to give an idea of how it works, we consider the
simple case when u˜(t)   0. In this case, letting  M = M(x) M⇤:
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.z}|{
 M = M˙(x) =
⇥
1 1 1
⇤
x˙(t)
= ↵
⇥
1 1 1
⇤
Ax(t) + ↵
 
3X
i=1
bi
!
⇥
⇥
0@  3X
i=1
bi
! 1  ⇥
1 1 1
⇤
Ax(t) +   (M(x) M⇤) 
1A
=  ↵  (M(x) M⇤)
=  ↵  M =   ↵ M
(5)
Since ↵ and   are positive,   ↵ < 0 and hence  M converges to zero, i.e.,M(x)
converges to M⇤.
Thus, the patient parameter ↵ may indeed be left out of the control law for
the rocuronium mass. Although ↵ influences the in the speed of convergence,
this can be compensated by the design parameter  . As can be seen in (5) the
controller action just depends on a suitable choice of the value for the desired
massM⇤. To compute this value, the equilibrium point of the closed-loop system,
when M(x) = M⇤ was determined and the steady-state e↵ect concentration ce
was shown to be equal to M
⇤
3 . This enables to determine the value of the desired
mass M⇤ by the inversion of the Hill equation (3) for a desired set-point value
y⇤ for the NMB level. According the clinicians, during general anesthesia, this
desired value should be equal to 10%.
Indeed, we have
M⇤ = 3⇥
✓
100
y⇤
  1
◆1/ 
C50 = 3⇥ 91/ C50 (6)
Thus, once the patient-dependent parameter   is known, the value of M⇤ is
obtained by equation (6).
2.3 Parameter estimation
Although, the controller action does not depend from the parameter of the linear
model, the determination of the suitable mass M⇤ depends on the parameter  .
In order to obtain the value of this parameter, a simple procedure for parameter
estimation will be performed. Note that,   appears in the Hill equation,
y(t) =
100
1 +
⇣
ce(t)
C50
⌘  (7)
This parameter is identified when the controller action begins which corre-
sponds to time instant of the initial recovery after an initial bolus. This time of
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recovery, t⇤, is given by the algorithm OLARD [8]. So, at this time instant, an
estimate  ˆ of   is obtained by the inversion of the Hill equation
 ˆ =
log
⇣
100
y(t⇤)   1
⌘
log
⇣
ce(t⇤)
C50
⌘ (8)
3 Simulation results
This section presents the results obtained by the application of the control
scheme proposed here to control the NMB level via the administration of the
muscle relaxant rocuronium. Fifty real cases were collected using the Galeno
platform developed in the framework of the Portuguese funding agency (FCT)
project Galeno, that incorporates several identification and control procedures
for automation in the administration of anesthetics. Furthermore, a Prediction
Error Method was used to identify the patient-dependent parameters: ✓i =
(↵i,  i), i = 1, . . . , 50. Here, the values for the parameters corresponding to
the patient number seven were used to represent the real patient and to obtain
the real response: ✓7 = (0.0293, 1.4728). The values of k1, k2 and k3 are fixed
Fig. 1. NMB level evolution obtained with the application of the proposed control
scheme applied at t⇤ = 41.3min.
and equal to 1, 9 and 10 respectively, and the values of C50 is 1 [7]. The value
for the design parameter  ↵ was taken as 0.2.
Since for simplicity, we chose not to identify the parameter ↵, the control
scheme is designed taking into account its mean value ↵: ↵¯ = 0.0307.
Moreover the identification of the parameter   of the nonlinear model at
the time instant t⇤ = 41, 3min is performed as mentioned in equation (8). The
value of the estimated parameter is  ˆ = 1.4755. The proposed control scheme is
applied from the time instant t⇤ on considering the obtained estimated for the
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parameter  . Fig. 1 shows the patient response and the input signal obtained by
applying the described strategy.
To analyze the performance of the identification procedure, the controlled
NMB response was obtained considering the following scenarios:
1. ↵¯,  ¯, i.e., mean values for ↵ and   ( ¯ = 1.8499);
2. ↵¯,  ˆ, i.e., mean value for ↵ and the estimate obtained by the identification
procedure for  .
The corresponding results can be observed in Fig. 2. As it is possible to see,
Fig. 2. NMB level evolution for the scenarios (1) and (2) when the control law is
applied at t⇤ = 41.3min.
with our identification procedure the NMB level tracks the desired NMB level
of 10%.
In order to analyze the performance of the control scheme under a more
realistic scenario, a noise signal was added to the real response. The noise signal
was obtained from a typical NMB real case. For this scenario, the value of  ˆ is
1.3660. Fig. 3 shows the NMB level evolution and the input signal when noise is
considered.
4 Conclusions
In this paper a new simplified control scheme for the neuromuscular blockade
that only requires the knowledge of the parameter of the nonlinear part of the
model is proposed. The control law is designed to control the amount of the
muscle relaxant that should be administered during a general anesthesia to track
a desired NMB level of 10% . In order to obtain the aforementioned parameter,
an identification procedure based on the patient’s response was also proposed.
The results were validated by simulations based on real collected data; although
this is a preliminary study, the result are encouraging.
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Fig. 3. NMB level evolution obtained with the application of the proposed control
scheme at t⇤ = 41.3min when noise is added to the real signal.
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